Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lea Wagmann

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Metabolites|August 27, 2025
A Comparative Study Using Reversed-Phase and Hydrophilic Interaction Liquid Chromatography to Investigate the In Vitro and In Vivo Metabolism of Five Selenium-Containing Cathinone DerivativesLea Wagmann, Jana H Schmitt, Tanja M Gampfer, et al.
British Journal of Clinical Pharmacology|June 16, 2025
Metabolic fate of drugs of abuse and new psychoactive substances: A pilot study on a novel workflow using a zebrafish embryo model combined with human microdosingSimon K Wellenberg, Tanja M Gampfer, Lea Wagmann, et al.
Frontiers in Chemistry|August 9, 2020
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish LarvaeLea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Toxicology Letters|January 26, 2019
Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes - A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvaeLilian H J Richter, Jennifer Herrmann, Anastasia Andreas, et al.
Archives of Toxicology|July 11, 2025
Polyclonal antibodies towards abrin and ricin-design and potential application for mass spectrometry-based analysis of human biosamplesAline C Vollmer, Claudia Fecher-Trost, Martin Jung, et al.
Biochemical Pharmacology|February 1, 2015
P-glycoprotein interactions of novel psychoactive substances - stimulation of ATP consumption and transport across Caco-2 monolayersMarkus R Meyer, Lea Wagmann, Nicole Schneider-Daum, et al.
Neuropharmacology|November 23, 2019
Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)Adam L Halberstadt, Muhammad Chatha, Adam K Klein, et al.
Scientific Reports|May 10, 2023
Evaluation of extraction methods for untargeted metabolomic studies for future applications in zebrafish larvae infection modelsPhilip Schippers, Sari Rasheed, Yu Mi Park, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2024
Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assayTanja M Gampfer, Victoria Schütz, Philip Schippers, et al.
Archives of Toxicology|April 7, 2020
Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidineTanja M Gampfer, Lea Wagmann, Yu Mi Park, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Metabolites|August 27, 2025
A Comparative Study Using Reversed-Phase and Hydrophilic Interaction Liquid Chromatography to Investigate the In Vitro and In Vivo Metabolism of Five Selenium-Containing Cathinone DerivativesLea Wagmann, Jana H Schmitt, Tanja M Gampfer, et al.
British Journal of Clinical Pharmacology|June 16, 2025
Metabolic fate of drugs of abuse and new psychoactive substances: A pilot study on a novel workflow using a zebrafish embryo model combined with human microdosingSimon K Wellenberg, Tanja M Gampfer, Lea Wagmann, et al.
Frontiers in Chemistry|August 9, 2020
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish LarvaeLea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Toxicology Letters|January 26, 2019
Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes - A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvaeLilian H J Richter, Jennifer Herrmann, Anastasia Andreas, et al.
Archives of Toxicology|July 11, 2025
Polyclonal antibodies towards abrin and ricin-design and potential application for mass spectrometry-based analysis of human biosamplesAline C Vollmer, Claudia Fecher-Trost, Martin Jung, et al.
Biochemical Pharmacology|February 1, 2015
P-glycoprotein interactions of novel psychoactive substances - stimulation of ATP consumption and transport across Caco-2 monolayersMarkus R Meyer, Lea Wagmann, Nicole Schneider-Daum, et al.
Neuropharmacology|November 23, 2019
Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)Adam L Halberstadt, Muhammad Chatha, Adam K Klein, et al.
Scientific Reports|May 10, 2023
Evaluation of extraction methods for untargeted metabolomic studies for future applications in zebrafish larvae infection modelsPhilip Schippers, Sari Rasheed, Yu Mi Park, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2024
Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assayTanja M Gampfer, Victoria Schütz, Philip Schippers, et al.
Archives of Toxicology|April 7, 2020
Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidineTanja M Gampfer, Lea Wagmann, Yu Mi Park, et al.
Pageof 8